Cargando…
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
BACKGROUND: Alzheimer's disease (AD) brain shows an ongoing inflammatory condition and non-steroidal anti-inflammatories diminish the risk of suffering the neurologic disease. Cannabinoids are neuroprotective and anti-inflammatory agents with therapeutic potential. METHODS: We have studied the...
Autores principales: | Martín-Moreno, Ana María, Brera, Begoña, Spuch, Carlos, Carro, Eva, García-García, Luis, Delgado, Mercedes, Pozo, Miguel A, Innamorato, Nadia G, Cuadrado, Antonio, de Ceballos, María L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/ https://www.ncbi.nlm.nih.gov/pubmed/22248049 http://dx.doi.org/10.1186/1742-2094-9-8 |
Ejemplares similares
-
Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice
por: Honarpisheh, Pedram, et al.
Publicado: (2020) -
Defined astrocytic expression of human amyloid precursor protein in Tg2576 mouse brain
por: Heiland, Tina, et al.
Publicado: (2018) -
A Novel Form of Compensation in the Tg2576 Amyloid Mouse Model of Alzheimer’s Disease
por: Somogyi, Attila, et al.
Publicado: (2016) -
In Vivo Turnover of Tau and APP Metabolites in the Brains of Wild-Type and Tg2576 Mice: Greater Stability of sAPP in the β-Amyloid Depositing Mice
por: Morales-Corraliza, Jose, et al.
Publicado: (2009) -
Oxidative Stress during the Progression of β-Amyloid Pathology in the Neocortex of the Tg2576 Mouse Model of Alzheimer's Disease
por: Porcellotti, Sara, et al.
Publicado: (2015)